GL1X · GenesisL1 explorer

Research workbench

Design and optimization of biaryl ether aryl sulfonamides as selective inhibitors of NAV1.7: discovery of clinical candidate pf-05089771

Analyse Design and optimization of biaryl ether aryl sulfonamides as selective… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5K7K
Type
protein
Length
455 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytochrome P450 2C9
EC
1.14.13.80
UniProt
P11712
Ligands
HEM, 6RJ
Pockets
5 · best druggability 0.87

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACytochrome P450 2C9 (EC 1.14.13.80)protein45549% helix, 10% strandP11712

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · chains A
  • 6RJ · 4-[4-chloranyl-2-(1~{H}-pyrazol-4-yl)phenoxy]-3-cyano-~{N}-(1,3-thiazol-2-yl)benzenesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110260.870.8896HEM, 6RJ
21370.460.7730empty
31380.430.7523empty
4660.350.7713empty
5580.340.7813empty

Compared structures

  • 5K7K · Design and Optimization of Biaryl Ether Aryl Sulfonamides as Selective Inhibitors of… · the same entry in another collection · chain A against A, TM-score 1.00
  • P11712 · AlphaFold monomer V2.0 prediction for cytochrome P450 2C9 (P11712) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.